drugset
drugset / Trial / NCT02228005

The Effect of a Selective Serotonin Reuptake Inhibitor on Gait, Balance, and Bone Metabolism in Older Adults

NCT02228005 ↗

Phase 4 Completed 25 enrolled University Health Network, Toronto
Non-randomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to examine the effects of sertraline treatment of depression in older adults on gait stability, balance recovery reactions, and markers of bone metabolism. This is a pilot study that will determine feasibility and generate hypotheses for a larger definitive study.

Timeline

Start
2014-07
Primary completion
2016-07
Completion
2016-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Sertraline Small molecule 200 mg —

Indications

depressive disorder